GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: example 485 [US20250154137]
Compound class:
Synthetic organic
Comment: The chemical structure for this compound was obtained from WHO INN proposed list 134 (Feb 2026), in which it is described as a glucagon-like peptide 1 (GLP-1) receptor agonist (GLP-1RA) with antidiabetic potential. The structure and its use are claimed in patents held by Carmot Therapeutics [1]. Carmot is now a Roche subsidiary. There is only one declared GLP-1RA in the development pipeline, CT-996 (RG6652; RO7795081). Although the structure for CT-996 is undisclosed (March 2026) we can hazard a guess that tifeglipron is likely the INN match for CT-996. Roche officially describe CT-996 as a cAMP-biased agonist, with minimal effect on β-arrestin recruitment.
Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
|||||||||||||||||||||||||||||||||||
Download 2D Structure ![]() |
|
| Canonical SMILES | Download |
| Isomeric SMILES | Download |
| InChI standard identifier | Download |
| InChI standard key | Download |
Molecular structure representations generated using Open Babel